BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 19415021)

  • 1. Disseminated nasal-type natural killer/T-cell lymphoma in a child: a case report.
    Pellier I; N'Golet L; Rachieru P; Rousselet MC; Geneviève F; Moles MP; Hermine O; Rialland X
    J Pediatr Hematol Oncol; 2009 May; 31(5):362-6. PubMed ID: 19415021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of concurrent chemoradiotherapy for stage I nasal NK/T cell lymphoma: a report of two cases.
    Niibe Y; Hayakawa K; Kitano M; Ishiyama H; Nakayama M; Yao K; Okamoto M
    Anticancer Res; 2005; 25(6C):4403-6. PubMed ID: 16334116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Midline NK/T-cell lymphoma nasal-type: treatment outcome, the effect of L-asparaginase based regimen, and prognostic factors.
    Yong W; Zheng W; Zhu J; Zhang Y; Wei Y; Wang X; Lin N; Xie Y; Xu B; Li J
    Hematol Oncol; 2006 Mar; 24(1):28-32. PubMed ID: 16323259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognostic analysis of patients with nasal-type NK/T-cell non-Hodgkin's lymphoma--a report of 93 cases].
    Pan ZH; Huang HQ; Lin XB; Xia YF; Xia ZJ; Peng YL; Cai QQ; Lin TY; Jiang WQ; Guan ZZ
    Ai Zheng; 2005 Dec; 24(12):1493-7. PubMed ID: 16351799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extranodal nasal type NK/T-cell lymphoma: elucidating clinical prognostic factors for risk-based stratification of therapy.
    Lee J; Park YH; Kim WS; Lee SS; Ryoo BY; Yang SH; Park KW; Kang JH; Park JO; Lee SH; Kim K; Jung CW; Park YS; Im YH; Kang WK; Lee MH; Ko YH; Ahn YC; Park K
    Eur J Cancer; 2005 Jul; 41(10):1402-8. PubMed ID: 15963893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Exploration of prognostic factors in extranodal nasal-type NK/T cell lymphoma].
    Han DM; Chen XQ; Bai QX
    Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):137. PubMed ID: 16750021
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunohistochemical expression and clinical significance of P-glycoprotein in previously untreated extranodal NK/T-cell lymphoma, nasal type.
    Wang B; Li XQ; Ma X; Hong X; Lu H; Guo Y
    Am J Hematol; 2008 Oct; 83(10):795-9. PubMed ID: 18756548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma/leukemia: different genomic alteration patterns of aggressive NK-cell leukemia and extranodal Nk/T-cell lymphoma, nasal type.
    Nakashima Y; Tagawa H; Suzuki R; Karnan S; Karube K; Ohshima K; Muta K; Nawata H; Morishima Y; Nakamura S; Seto M
    Genes Chromosomes Cancer; 2005 Nov; 44(3):247-55. PubMed ID: 16049916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiotherapy alone for nasal natural-killer/T-cell lymphoma.
    Bahl G; Laskar S; Muckaden MA
    J Clin Oncol; 2006 Jun; 24(17):2684-5; author reply 2685-6. PubMed ID: 16763286
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment outcome of angiocentric T-cell and NK/T-cell lymphoma, nasal type: radiotherapy versus chemoradiotherapy.
    Kim K; Chie EK; Kim CW; Kim IH; Park CI
    Jpn J Clin Oncol; 2005 Jan; 35(1):1-5. PubMed ID: 15681596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extranodal nasal-type natural killer T-cell lymphoma in an adolescent from Bangladesh.
    Pol-Rodriguez MM; Fox LP; Sulis ML; Miller IJ; Garzon MC
    J Am Acad Dermatol; 2006 May; 54(5 Suppl):S192-7. PubMed ID: 16631938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nasal natural killer/T-cell lymphoma and its association with type "i"/XhoI loss strain Epstein-Barr virus in Chile.
    Cabrera ME; Eizuru Y; Itoh T; Koriyama C; Tashiro Y; Ding S; Rey S; Akiba S; Corvalan A
    J Clin Pathol; 2007 Jun; 60(6):656-60. PubMed ID: 16775124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nasal T/NK cell lymphoma: report of 3 cases involving the palate.
    Tsang WM; Tong AC; Lam KY; Tideman H
    J Oral Maxillofac Surg; 2000 Nov; 58(11):1323-7. PubMed ID: 11078150
    [No Abstract]   [Full Text] [Related]  

  • 14. Cutaneous dissemination of nasal NK/T-cell lymphoma in a young girl.
    Sandner A; Helmbold P; Winkler M; Gattenlöhner S; Müller-Hermelink HK; Holzhausen HJ
    Clin Exp Dermatol; 2008 Aug; 33(5):615-8. PubMed ID: 18616730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nasal NK/T lymphoma. A case report].
    Ladeb S; Gaulard P; Ben Othmen T; Abd Alsamad I; Delfau-Larue MH; Abdelkefi A; Torjmen L; Ben Abdeladhim A
    Ann Pathol; 2003 Apr; 23(2):149-52. PubMed ID: 12843969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three cases of extranodal NK/T-cell lymphoma of the nasal type diagnosed by nasal brush cytology.
    Kishimoto K; Kitamura T; Hirayama Y; Tate G; Mitsuya T
    Diagn Cytopathol; 2007 Feb; 35(2):125-9. PubMed ID: 17230578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extranodal NK/T cell lymphoma presenting as palatal perforation with oronasal fistula.
    Chaudhary SV; Karnik ND; Sabnis GR; Patil MV; Bradoo RA
    J Assoc Physicians India; 2011 Feb; 59():112-4. PubMed ID: 21751648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical characteristics and treatment of midline nasal and nasal type NK/T cell lymphoma].
    Yong W; Zheng W; Zhang Y
    Zhonghua Yi Xue Za Zhi; 2001 Jul; 81(13):773-5. PubMed ID: 11798962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of interleukin-9 in nasal natural killer/T-cell lymphoma cell lines and patients.
    Nagato T; Kobayashi H; Kishibe K; Takahara M; Ogino T; Ishii H; Oikawa K; Aoki N; Sato K; Kimura S; Shimizu N; Tateno M; Harabuchi Y
    Clin Cancer Res; 2005 Dec; 11(23):8250-7. PubMed ID: 16322282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiotherapy as primary treatment for stage IE and IIE nasal natural killer/T-cell lymphoma.
    Li YX; Yao B; Jin J; Wang WH; Liu YP; Song YW; Wang SL; Liu XF; Zhou LQ; He XH; Lu N; Yu ZH
    J Clin Oncol; 2006 Jan; 24(1):181-9. PubMed ID: 16382127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.